ArticleFrontiers in oncology2025
Case Report: Diagnostic challenges in differentiated-type vulvar intraepithelial neoplasia.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Differentiated-type vulvar intraepithelial neoplasia (dVIN) is typically HPV-independent and is most strongly linked to HPV-independent keratinizing squamous cell carcinoma (often well- to moderately differentiated). It commonly shows aberrant p53 and p16-negative immunophenotype. As such, dVIN carries a higher risk of progression to invasion and metastasis, tends to progress to carcinoma more rapidly, and predominantly affects older women. In this study, we report two cases of vulvar squamous cell carcinoma (VSCC) associated with dVIN, aiming to enhance awareness of its pathological and clinical features. In both cases, the patients tested negative for human papillomavirus (HPV), and the tumors presented as well-differentiated, keratinizing squamous cell carcinoma (keratinizing SCC) with lymph node metastasis. In Case 1, the initial pathological diagnosis was misinterpreted as inflammation or mild-to-moderate epithelial hyperplasia. It was only upon lymph node metastasis and further immunohistochemical review (including mutant-type p53, negative p16, and positive CK17 and SOX2) that dVIN was confirmed, suggesting a possible early microinvasive lesion that had been overlooked. In Case 2, the ulcerated, bleeding lesion was diagnosed as SCC with adjacent areas of dVIN, supported by immunohistochemical findings. These two cases highlight that although dVIN may appear histologically subtle, it can directly progress to SCC and even metastasize when overt invasion is not appreciated on the index biopsy. It may be prudent to maintain increased vigilance for persistent vulvar lesions, particularly in HPV-negative and histologically ambiguous settings. Comprehensive assessment (including immunohistochemistry) may facilitate earlier detection and more accurate diagnosis, thereby potentially improving treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.